文献速递心律失常冠心病

TAVI术前合并房颤患者一年随访结果

[One-year follow-up results of atrial fibrillation patients who undergoing transcatheter aortic valve implantation].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2022-01-01

单中心回顾性研究纳入115例成功接受TAVI的重度主动脉瓣狭窄患者,按术前有无房颤分为房颤组21例和非房颤组94例,随访12个月。房颤组严重出血发生率显著高于非房颤组(9.5%比0,P=0.032),NACCE发生率有数值升高趋势但无统计学差异(14.3%比6.4%,P=0.441)。

要点

  • TAVI术前合并房颤者术后12个月严重出血风险显著高于无房颤者。
  • 房颤组NACCE发生率数值上更高,但差异无统计学意义。
  • 高血压与NACCE风险相关(OR=8.308,P=0.050),房颤与NACCE无关。

核心结论

  • TAVI术前合并房颤患者术后严重出血发生率高于非房颤患者,NACCE发生率有增加趋势。

研究设计与样本

  • 单中心回顾性研究,纳入2016年5月至2020年11月北部战区总医院成功接受TAVI的重度主动脉瓣狭窄患者115例,按术前有无房颤分为房颤组21例和非房颤组94例。

主要发现

  • 房颤组TAVI术后12个月NACCE发生率为14.3%(3/21),非房颤组为6.4%(6/94),差异无统计学意义(P=0.441)。
  • 房颤组严重出血发生率为9.5%(2/21),非房颤组为0,差异有统计学意义(P=0.032)。
  • 单因素logistic回归显示高血压与NACCE风险相关(OR=8.308,P=0.050),房颤与NACCE风险无关(P=0.235)。

关键数值与推荐

  • 非房颤组48.9%(46/94)接受单药抗血小板治疗,47.9%(45/94)接受双联抗血小板治疗。
  • 房颤组47.6%(10/21)使用抗凝药,33.3%(7/21)接受双联抗血小板治疗。
  • 房颤组服用NOAC比例高于非房颤组[38.1%(8/21)比2.1%(2/94),P<0.001]。

临床怎么用

  • TAVI术前应评估房颤状态,合并房颤者术后需加强出血监测与抗栓方案个体化管理。

局限性

  • 单中心回顾性研究,样本量较小,房颤组仅21例,结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate whether atrial fibrillation (AF) before transcatheter aortic valve implantation (TAVI) will affect the prognosis of patients post TAVI. Methods: This is a single center retrospective study. A total of 115 patients with severe aortic stenosis (AS) who were admitted to General Hospital of Northern Theater Command from May 2016 to November 2020 and successfully received TAVI treatment were included. According to absence or accompaniment of AF pre-TAVI, they were divided into AF group (21 cases) and non-AF group (94 cases). The patients were followed up for postoperative antithrombotic treatment and the occurrence of the net adverse clinical and cerebrovascular events (NACCE) at 12 months post TAVI, including cardiogenic death, readmission to hospital for heart failure, nonfatal myocardial infarction, ischemic stroke and severe bleeding (BARC levels 3-5). Univariate logistic regression was used to analyze the related factors of NACCE. Results: Among the 115 selected patients, age was (73.8±6.9) years, there were 63 males. And 21 cases (18.2%) were diagnosed as AFbefore TAVI. In terms of postoperative antithrombotic therapy, 48.9% (46/94) of the patients in the non-AF group received monotherapy and 47.9% (45/94) received dual antiplatelet therapy. In the AF group, 47.6% (10/21) received anticoagulants and 33.3% (7/21) received dual antiplatelet therapy. The proportion of patients in the AF group taking non-vitamin K antagonist oral anticoagulants (NOAC) was higher than that in the non-AF group (38.1% (8/21) vs. 2.1% (2/94), P<0.001). Patients in both groups were followed up to 12 months after TAVI. During the 12 months follow-up, the incidence of NACCE after TAVI was 14.3% (3/21) in the AF group, which was numerically higher than that in the non-AF group (6.4% (6/94)), but the difference was not statistically significant (P=0.441). The incidence of severe bleeding was significantly higher in the AF group than in the non-AF group (9.5% (2/21) vs. 0, P=0.032). Univariate logistic regression analysis showed that hypertension was associated with the risk of NACCE (OR=8.308, P=0.050), while AF was not associated with the risk of NACCE (P=0.235). Conclusion: The incidence of severe bleeding after TAVI is higher in patients with AF than in patients without AF prior TAVI, and there is a trend of increased risk of NACCE post TAVI in AF patients. 目的: 探讨经导管主动脉瓣植入(TAVI)术前合并心房颤动(房颤)是否会对患者的预后产生影响。 方法: 本研究为单中心回顾性研究。入选2016年5月至2020年11月于北部战区总医院住院并成功接受TAVI治疗且顺利出院的重度主动脉瓣狭窄患者115例。根据入选患者是否合并房颤将其分为房颤组(21例)及非房颤组(94例)。随访纳入患者的术后抗栓治疗情况及终点事件的发生情况,终点事件为12个月的净不良心脑血管事件(NACCE),包括心原性死亡、因心力衰竭再入院、非致死性心肌梗死、缺血性卒中及严重出血[出血学术研究联合会(BARC)定义的3~5型出血]。采用单因素logistic回归分析NACCE事件的相关因素。 结果: 本研究共纳入115例成功接受TAVI并顺利出院的重度主动脉瓣狭窄患者,年龄(73.8±6.9)岁,男性63例,其中21例(18.2%)在TAVI术前诊断为房颤。在术后抗栓治疗方面,非房颤组患者中48.9%(46/94)接受了单药抗血小板治疗,47.9%(45/94)接受了双联抗血小板治疗。房颤组患者中47.6%(10/21)使用抗凝药,33.3%(7/21)接受了双联抗血小板治疗。房颤组患者中服用非维生素K拮抗剂口服抗凝药(NOAC)的比例高于非房颤组[38.1%(8/21)比2.1%(2/94),P<0.001]。两组患者均完成了术后12个月的随访。房颤组患者在TAVI术后12个月的NACCE发生率为14.3%(3/21),在数值上高于非房颤组[6.4%(6/94)],但差异无统计学意义(P=0.441)。房颤组患者的严重出血发生率高于非房颤组[9.5%(2/21)比0,P=0.032]。单因素logistic回归分析结果显示,高血压与NACCE发生风险相关(OR=8.308,P=0.050),而房颤与NACCE发生风险无关(P=0.235)。 结论: 房颤患者在TAVI术后严重出血发生率高于非房颤患者,NACCE发生率有增加的趋势。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhou, Xu, Wang, et al. [One-year follow-up results of atrial fibrillation patients who undergoing transcatheter aortic valve implantation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2022. PMID: 35172456. doi:10.3760/cma.j.cn112148-20211124-01016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。